Stock listing
PLYX Stock Price, News, Filings & Events — Polaryx Therapeutics, Inc.
Selected listing: PLYX · NASDAQ · USD · US
This page tracks Polaryx Therapeutics, Inc.'s PLYX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PLYX:NASDAQ. PLYX:NASDAQ is the stock-level entry point for investors researching Polaryx Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Polaryx Therapeutics, Inc. (ticker: PLYX) is a public company based in America, with a market capitalization of approximately $113.65 million. The company focuses on developing innovative therapies in the biotechnology sector. Investors can find more information about its operations and performance on its dedicated public company page.

- Ticker
- PLYX:NASDAQ
- Asset type
- Stock
- Market cap
- $129.6M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- NASDAQ
- Currency
- USD
Polaryx Therapeutics, Inc. PLYX:NASDAQ stock context
This page tracks Polaryx Therapeutics, Inc.'s PLYX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PLYX:NASDAQ. PLYX:NASDAQ is the stock-level entry point for investors researching Polaryx Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Polaryx Therapeutics, Inc. (ticker: PLYX) is a public company based in America, with a market capitalization of approximately $113.65 million. The company focuses on developing innovative therapies in the biotechnology sector. Investors can find more information about its operations and performance on its dedicated public company page.
Latest news from Polaryx Therapeutics, Inc.
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
August 25, 2026
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
May 28, 2026
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference
April 23, 2026
Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial
April 21, 2026
Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care
April 15, 2026
Research Polaryx Therapeutics, Inc.
Polaryx Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for PLYX:NASDAQ.
Polaryx Therapeutics, Inc. company profile
View the public company page for Polaryx Therapeutics, Inc. on 6ix.
Polaryx Therapeutics, Inc. news
Read company news and market updates connected to Polaryx Therapeutics, Inc..
Polaryx Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Polaryx Therapeutics, Inc..